The out-of-pocket payments for prescription medications can impose financial burden on patients from low- and middle- income and who suffer from chronic diseases. The present study aimed at evaluating the affordability of Cardiovascular diseases (CVDs) medication in Iran. This includes measuring affordability through World Health Organization/Health Action International (WHO/HAI) methodology. In this method, affordability was characterized as the number of days' 28 wages of the lowest-paid unskilled government worker. The different medication therapy scenarios were defined in mono-and combination therapy approaches. This method adds on to WHO/HAI methodology to discover new approaches to affordability assessment. The results show the differences in the medicines affordability when different approaches were used in mono-and combination therapy between 6 main sub-therapeutic groups of CVD. It indicates the medicine affordability isn’t a static concept and it changed dynamically between CVD therapeutic subgroups when it used alone or in combination of other medicines regarding patients’ characteristics and medical conditions. The hypertension and anti-arrhythmia therapeutic groups had the most non36 affordable and hyperlipidemia had most affordable medicines. Therefore, the affordability can be considered as a dynamic concept, which not only affected by the medicine price, but significantly affected by patient’s characteristics, number of medical conditions, and insurance coverage.
|Number of pages||20|
|Journal||International Journal of Environmental Research and Public Health|
|Publication status||Published - 5 Mar 2020|
Zarei , L., Karimzadeh, I., Moradi , N., Peymani , P., Asadi , S., & Babar, Z-U-D. (2020). Affordability Assessment from a Static to Dynamic Concept: A Scenario-Based Assessment of Cardiovascular Medicines. International Journal of Environmental Research and Public Health, 17(5), .